Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer

Equality Impact Assessment (Guidance development) (PDF 139 KB)

Final draft guidance

Final appraisal document (PDF 368 KB)

Committee papers (PDF 466 KB)

Final appraisal document TA831 - Final Appraisal Document (PDF 353 KB)

Committee papers TA831 - Final Appraisal Document Committee papers (PDF 634 KB)

Appraisal consultation document (PDF version) TA831 - 2nd Appraisal Consultation Document (PDF 359 KB)

Committee papers TA831 - 2nd Appraisal Consultation Document Committee papers (PDF 688 KB)

Appraisal consultation document (PDF version) TA831 - 1st Appraisal Consultation Document (PDF 340 KB)